知镜 Cognispect · 医学文献与研究工作台

Geographic distance and overall survival among patients receiving non-palliative radiotherapy: a diagnosis-stratified real-world cohort study.

Wals-Zurita AJW, González Ruiz M, Pachón-Ibáñez JP, Muñoz-Carmona DMM, Illescas-Vacas AI, Ortiz-Bautista YCO, Guerrero-Rodríguez SG.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026-10-29 · PMID 42955646

文献摘要

Purpose To determine whether residential distance to a tertiary radiotherapy centre is associated with overall survival among patients receiving non-palliative radiotherapy, while accounting for diagnostic heterogeneity and repeated treatment episodes. Methods We conducted a retrospective single-centre cohort study of patients receiving non-palliative radiotherapy for six prevalent cancer groups. The first eligible treatment episode per patient defined the primary cohort. Orthodromic distance was evaluated in five categories, continuously and with restricted cubic splines. Cox regression was stratified by diagnosis and adjusted for age, sex and mobility. Secondary analyses examined clinical-variable availability, models with available stage and/or ECOG, diagnosis-by-distance heterogeneity, treatment intent, fractionation, treatment year and all eligible episodes with patient-clustered robust standard errors. Results The primary analysis included 5,690 patients and 1,012 deaths. Median distance was 14.4 km; 94.3% lived within 60 km. There was no evidence of an association between categorical distance and mortality in the diagnosis-stratified model adjusted for available measured covariates (global P=0.491). Compared with ≤10 km, adjusted hazard ratios were 1.16 for 10-20 km, 0.96 for 20-40 km, 1.02 for 40-60 km and 1.06 for >60 km. The continuous estimate was 1.02 per 25 km (95% confidence interval 0.96-1.09; P=0.452). Distance estimates remained materially unchanged in clinical complete-case and recent-period sensitivity analyses. No formal evidence of distance-effect heterogeneity by diagnosis was detected (interaction P=0.111). Conclusions Among patients who received non-palliative radiotherapy in this compact referral area, residential distance was not detectably associated with overall survival after adjustment for available measured variables and diagnosis-stratified baseline hazards. These findings do not evaluate geographic access before radiotherapy receipt and do not exclude moderate effects among long-distance patients.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。